---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-24-000054"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:30:14.745968+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q4 revenue +12% to $59.9B, non-GAAP EPS $1.84 (+29%); raises FY25 guidance to $7.55-$7.70

## Summary
- Q4 revenue $59.9B (+12% YoY); GAAP EPS $0.96, non-GAAP EPS $1.84 (+29%).
- FY2024 revenue $226.8B (+11%), non-GAAP EPS $7.53 (+29%); operating cash flow record $3.8B.
- FY2025 non-GAAP EPS guidance raised to $7.55-$7.70 from at least $7.50.
- Pharmaceutical & Specialty Solutions segment profit +8% to $482M; GMPD profit $47M vs $7M YoY.
- GMPD segment profit improved $40M to $47M driven by net inflationary mitigation initiatives.

## SEC filing metadata
- accession: 0000721371-24-000054
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/0000721371-24-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000054/cah-20240814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-24-000054
- JSON: https://secwatch.observer/filing/0000721371-24-000054.json
- Plain text: https://secwatch.observer/filing/0000721371-24-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.